Europe In-Vitro Fertilization Market Growth, Size, Trends, Revenue, Demand and Future Outlook
Europe In-Vitro Fertilization (IVF) Market Size- By Cycle Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Feb-2024 | Report ID: HLCA2423 | Pages: 1 - 154 | Formats*: |
| Category : Healthcare | |||
Europe In-Vitro Fertilization (IVF) Market Introduction and Overview
According to SPER Market Research, the Europe In-Vitro Fertilization (IVF) Market is estimated to reach USD 7.28 Billion by 2033 with a CAGR of 5.6%.
The report includes an in-depth analysis of the Europe In-Vitro Fertilization (IVF) Market, including market size and trends, product mix, applications, and supplier analysis. Throughout the clinical sector, in vitro fertilisation is one kind of assisted reproductive technology-based fertility treatment. Since the likelihood of conceiving decreases with age, delayed conception in women is a significant element driving the IVF industry. The age range of 35–39 years old has a higher success rate when using the IVF process to get pregnant.
-00459016022024.jpg)
Market Opportunities and Challenges
The European IVF market is expected to be driven by factors such as growing support for the expansion of infertility clinics and services throughout Europe, a growing emphasis on fertility protection initiatives among market participants, and education aimed at strengthening the network for exchanging best practices and concise information on infertility and fertility. Due to the continent's expanding population and the growing trend of women delaying conception, there are a significant number of IVF centres throughout Europe. Additionally, the likelihood of conceiving naturally declines with age, which raises the number of infertility issues. Consequently, a greater number of women are compelled to employ in vitro fertilisation banking services in order to increase the success rate, which is anticipated to spur market expansion. Furthermore, it is projected that the IVF industry will continue to expand because these centres work to remove the stigma attached to infertility by offering public support for all reproductive treatment options.
The expansion of the European IVF business is also being aided by rising awareness of the range of infertility treatment options available. Additionally, the market participants' increasing efforts to raise awareness of infertile centres and infertility treatment through social media and television aid in spreading knowledge about the cost and course of treatment, which encourages treatment adoption among those living in rural areas and those with low levels of education.
However, it is projected that stringent government controls and the high prices of IVF treatments will slow the growth pace of the regional industry. Furthermore, because IVF operations have a lower success rate, a patient can require many pregnancy cycles, which raises the overall cost. The typical cost of this operation is between USD 15,125 and USD 25,300, which is frequently a major deterrent to using the method. The absence of reimbursement and ethical issues are two other obstacles impeding the market's expansion. Furthermore, the absence of reimbursements and ethical objections to IVF impede the expansion of the European IVF business.
-00458546022024.jpg)
Market Competitive Landscape
The major key players in the Europe In-Vitro Fertilization (IVF) Market are: Cadila Healthcare Ltd., DRK Kliniken Berlin, EMD Serono Inc., LG Life Sciences, Sun Pharmaceutical Industries Ltd., Thermo Fisher Scientific, Inc., Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Cycle Type, By End User |
| Regions covered | Denmark, France, Germany, Italy, Russia, Spain, UK, Rest of Europe |
| Companies Covered | Cadila Healthcare Ltd., DRK Kliniken Berlin, EMD Serono Inc., LG Life Sciences, Sun Pharmaceutical Industries Ltd., Thermo Fisher Scientific, Inc., Others |
COVID-19 Impact on Europe In-Vitro Fertilization (IVF) Market
The epidemic caused problems in the Europe In-Vitro Fertilisation (IVF) sector. IVF treatments were impacted by travel restrictions, lockdowns, and priorities within the healthcare system. There were delays and cancellations as a result of the temporary suspension of non-essential medical services, such as reproductive treatments. Patients were hesitant to undergo reproductive therapy due to uncertainties. But when regulations relaxed, the market showed signs of recovery and a renewed emphasis on safety precautions. In the IVF sector, the pandemic highlighted the value of resilience and strategic planning.
Key Target Audience
- Fertility Clinics and Centers
- Pharmaceutical Companies
- Medical Device Manufacturers
- Hospitals and Clinics
- Research Institutions
- Others
Our in-depth analysis of the Europe In-Vitro Fertilization (IVF) Market includes the following segments:
| By Cycle Type: |
|
| By End User: |
|
| By Region: |
|
Key Topics Covered in the Report
- Europe In-Vitro Fertilization (IVF) Market Size (FY’2023-FY’2033)
- Overview of Europe In-Vitro Fertilization (IVF) Market
- Segmentation of Europe In-Vitro Fertilization (IVF) Market By Cycle Type (Donor Egg IVF Cycle, Fresh Cycle, Thawed IVF Cycle)
- Segmentation of Europe In-Vitro Fertilization (IVF) Market By End User (Clinical Research Institutes, Fertility Clinics, Hospitals, Surgical Centers)
- Statistical Snap of Europe In-Vitro Fertilization (IVF) Market
- Expansion Analysis of Europe In-Vitro Fertilization (IVF) Market
- Problems and Obstacles in Europe In-Vitro Fertilization (IVF) Market
- Competitive Landscape in the Europe In-Vitro Fertilization (IVF) Market
- Impact of COVID-19 and Demonetization on Europe In-Vitro Fertilization (IVF) Market
- Details on Current Investment in Europe In-Vitro Fertilization (IVF) Market
- Competitive Analysis of Europe In-Vitro Fertilization (IVF) Market
- Prominent Players in the Europe In-Vitro Fertilization (IVF) Market
- SWOT Analysis of Europe In-Vitro Fertilization (IVF) Market
- Europe In-Vitro Fertilization (IVF) Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe In-Vitro Fertilization (IVF) Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe In-Vitro Fertilization (IVF) Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe In-Vitro Fertilization (IVF) Market
7. Europe In-Vitro Fertilization (IVF) Market, By Cycle Type (USD Million)
7.1. Europe In-Vitro Fertilization (IVF) Market Value Share and Forecast, By Cycle Type, 2023-20337.2. Donor Egg IVF Cycle7.3. Fresh Cycle (Non-Donor)7.4. Thawed IVF Cycle (Non-Donor)
8. Europe In-Vitro Fertilization (IVF) Market, By End User (USD Million)
8.1. Europe In-Vitro Fertilization (IVF) Market Value Share and Forecast, By End User, 2023-20338.2. Clinical Research Institutes8.3. Fertility Clinics8.4. Hospitals8.5. Surgical Centers
9. Europe In-Vitro Fertilization (IVF) Market Forecast, 2019-2033 (USD Million)
9.1. Europe In-Vitro Fertilization (IVF) Market Size and Market Share
10. Europe In-Vitro Fertilization (IVF) Market, By Cycle Type, 2019-2033 (USD Million)
10.1. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By Cycle Type (2019-2026)10.2. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By Cycle Type (2027-2033)
11. Europe In-Vitro Fertilization (IVF) Market, By End User, 2019-2033 (USD Million)
11.1. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By End User (2019-2026)11.2. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By End User (2027-2033)
12. Europe In-Vitro Fertilization (IVF) Market, By Region, 2019-2033 (USD Million)
12.1. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By Region (2019-2026)12.2. Europe In-Vitro Fertilization (IVF) Market Size and Market Share By Region (2027-2033)12.3. Denmark12.4. France12.5. Germany12.6. Italy12.7. Russia12.8. Spain12.9. UK12.10. Rest of Europe
13. Company Profile
13.1. Limited Cadila Healthcare Ltd.
13.1.1. Company details13.1.2. Financial outlook13.1.3. Product summary13.1.4. Recent developments
13.2. DRK Kliniken Berlin
13.2.1. Company details13.2.2. Financial outlook13.2.3. Product summary13.2.4. Recent developments
13.3. EMD Serono Inc.
13.3.1. Company details13.3.2. Financial outlook13.3.3. Product summary13.3.4. Recent developments
13.4. LG Life Sciences
13.4.1. Company details13.4.2. Financial outlook13.4.3. Product summary13.4.4. Recent developments
13.5. Sun Pharmaceutical Industries Ltd.
13.5.1. Company details13.5.2. Financial outlook13.5.3. Product summary13.5.4. Recent developments
13.6. Thermo Fisher Scientific, Inc.
13.6.1. Company details13.6.2. Financial outlook13.6.3. Product summary13.6.4. Recent developments
13.7. Others
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Europe In-Vitro Fertilization (IVF) Market is projected to reach USD 7.28 billion by 2033, growing at a CAGR of 5.6% during the forecast period.
Europe In-Vitro Fertilization (IVF) Market grew in Market size from 2022. The Market is expected to reach USD 7.28 billion by 2033, at a CAGR of 5.6% during the forecast period.
Europe In-Vitro Fertilization (IVF) Market CAGR of 5.6% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Europe In-Vitro Fertilization (IVF) Market size is USD 7.28 billion from 2023 to 2033.
Europe In-Vitro Fertilization (IVF) Market Segment is covered By Cycle Type, By End User.
The Europe is anticipated to have the highest Market share in the Europe In-Vitro Fertilization (IVF) Market.
The key players in the Market include Companies Covered Cadila Healthcare Ltd., DRK Kliniken Berlin, EMD Serono Inc., LG Life Sciences, Sun Pharmaceutical Industries Ltd., Thermo Fisher Scientific, Inc., Others.
The age range of 35–39 years old has a higher success rate when using the IVF process to get pregnant.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
